Navigation auf uzh.ch
Navigation auf uzh.ch
Boehringer Ingelheim is acquiring Saiba Animal Health, a UZH spin-off focused on developing novel therapeutic medicines for the treatment of chronic diseases in companion animals.
The TOP 100 Swiss Startup Ranking showcases the 100 Swiss startups with the greatest potential. Take a look at the success of UZH Spin-offs.
OxyPrem has developed a technology specifically designed to monitor oxygen levels in premature babies.
The Space Hub at the University of Zurich recently opened its doors to aerospace start-ups at the Innovation Park in Zurich.
ONtrack Biomedical AG is a UZH MedTech company that develops in-vitro diagnostic tests for the non-invasive early detection and monitoring of prostate cancer. ONtrack Biomedical was awarded the UZH Startup Label in 2024.
Synthara successfully closes a financing round of over USD 11 million.
In the 3rd Rapid-Action-Call of the DIZH Innovation Program, 6 projects are being funded, 5 with team members of UZH.
Kevin Yim wins with EVIIVE the first place in Switzerland's leading start-up competition >>venture>>, which recognizes the best business ideas and business plans in Switzerland.
The Innovation Hub's 2023 annual report provides an overview of innovation activities at UZH as well as inspiring stories – take a look.
The public voting for TOP 100 Swiss Startups is your chance to highlight an excellent Swiss startup. Please vote for entrepreneurs from the University of Zurich!
Over 20 participants responded to the call «Are you motivated to make a positive social impact?» and worked in interdisciplinary groups to develop digital solutions to current issues.
Oncobit, founded in 2018 as a UZH spin-off, announces partnership with Immunocore to advance therapy response analysis in clinical trials.
The UZH Life Science Fund awards CHF 1 million for FimmCyte.
Interview with Josua Jordi, CEO and co-founder of EraCal at the Innovator Mornings
The Deputy Head Innovation Office at the University of Zurich, Eva Maria Håkanson talks on the Swissnex San Francisco Podcast about moving ideas from the university to market.
Congratulations to UZH spin-off EraCal Therapeutics to their new partnering deal with Novo Nordisk. This is a huge step foward for the start-up, with a potential value of EUR 235 million, and brings revolutionary therapy for obesity one step closer to the market.
UZH researchers have co-founded Seito Biologics AG to develop a new treatment for autoimmunty. After several years of research at the Department of Immunology of the University of Zurich, the team is now ready to take the next step with their approach, which is based on selective Treg cell engagers (TREX).
In a collaborative project funded by Innosuisse and Enzian Pharmaceutics, scientists at Enzian Pharmaceutics and the University of Zurich (UZH) have reached an important milestone in the development of a new gastroretentive dosage form.
Arcton, a UZH startup and Zurich-based fintech startup founded in 2022, disrupts the Swiss crowdfunding scene with its innovative investing platform. Crowd investing in Switzerland has experienced a significant surge in popularity, with platforms primarily focused on capital raising.
On 6 September, the talent of the Swiss innovation ecosystem was showcased at the TOP 100 Swiss Startup Award 2023, organised by Venturelab.
Within both the Top 100 Swiss Startup Ranking and the TOP 100 Swiss Scale-up Ranking, multiple UZH spin-offs were named.
Venture Kick awarded CHF 150’000 to metaLead, a BioTech UZH Spinoff project, which is developing next-gen antidotes against toxic metals.
The Novartis Institutes for BioMedical Research (NIBR) is seeking to advance science through the NIBR Global Scholars Program (NGSP). This competitive program supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Magdalini Polymenidou has been selected for the NGSP 2022 and will receive up to 1 mil USD funding over three years along with scientific expertise from NIBR collaborators.
Research collaboration between EraCal Therapeutics and Nestlé Health Science
Prometheus AG wins the Orbital Reef Starter Innovation Challenge.
Former UZH MedTech Entrepreneur fellow David Gage and aiEndoscopic won the Swiss Innovation Challenge 2022.
UZH Entrepreneur Fellow Merens Derungs and his startup Arcton were among the illustrious circle of 6 startups that were allowed to present themselves at the Startup Nights in Winterthur.
Former MedTech UZH Entrepreneur fellow Dr. Deana Mohr and her company Muvon Therapeutics announce first patient enrolled in phase II clinical study.
Former MedTech UZH Entrepreneur fellow Dr. Prajwal and his company Clemedi release Tuberculini, a molecular test for drug-resistant tuberculosis.
Molecular biologist and former UZH Entrepreneur Fellow Ana Montalban-Arques has made a discovery that could cure colon cancer.
UZH Spin-off Synthara, a chip design startup founded by Manu V Nair and Alessandro Aimar, has been awarded the 2023 ZKB Technopark Pionierpreis. The Zurich-based company is recognised for its innovative approach to chip design, which enhances computing power and energy efficiency.
The majority of the spin-offs founded at the UZH are active in the fields of biotech and medicine. At the UZH Innovation Hub we support research projects in four innovation areas, including biotech and life sciences.
